返回
U
Univ. Montpellier
学者数3
论文数4
被引数169
关联论文 (554)
发表时间
ALBAN (GETUG-AFU 37): A phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladder cancer (NMIBC)ALBAN(GETUG-AFU 37):一项关于静脉注射阿替利珠单抗联合膀胱内注射卡介苗(BCG)与单独使用BCG治疗BCG初治高危非肌层浸润性膀胱癌(NMIBC)的3期、随机、开放标签、国际多中心临床试验
Annals of Oncology
IF65.4

